Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Dec;71(12):9538–9548. doi: 10.1128/jvi.71.12.9538-9548.1997

E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.

B M Pützer 1, H Rumpf 1, S Rega 1, D Brockmann 1, H Esche 1
PMCID: PMC230261  PMID: 9371617

Abstract

The transformation-defective Vero cell host range mutant CS-1 of the highly oncogenic adenovirus type 12 (Ad12) (Ad12-CS-1) has a 69-bp deletion in the early region 1A (E1A) gene that removes the carboxy-terminal half of conserved region 2 and the amino-terminal half of the Ad12-specific so-called spacer that seems to play a pivotal role in the oncogenicity of the virus. Despite its deficiency in immortalizing and transforming primary rodent cells, we found that the E1A 13S protein of Ad12-CS-1 retains the ability to bind p105-RB, p107, and p130 in nuclear extract binding assays with glutathione S-transferase-E1A fusion proteins and Western blot analysis. Like wild-type E1A, the mutant protein was able to dissociate E2F from retinoblastoma-related protein-containing complexes, as judged from gel shift experiments with purified 12S and 13S proteins from transfection experiments with an E1A expression vector or from infection with the respective virus. Moreover, in transient expression assays, the 12S and 13S products of wild-type Ad12 and Ad12-CS-1 were shown to transactivate the Ad12 E1A promoter containing E2F-1 and E2F-5-motifs, respectively, in a comparable manner. The same results were obtained from transfection assays with the E2F motif-dependent E2 promoter of adenovirus type 5 or the human dihydrofolate reductase promoter. These data suggest that efficient infection by Ad12 and the correlated virus-induced reprogramming of the infected cells, including the induction of cell cycle-relevant mechanisms (e.g. E2F activation), can be uncoupled from the transformation properties of the virus.

Full Text

The Full Text of this article is available as a PDF (859.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babich A., Nevins J. R. The stability of early adenovirus mRNA is controlled by the viral 72 kd DNA-binding protein. Cell. 1981 Nov;26(3 Pt 1):371–379. doi: 10.1016/0092-8674(81)90206-3. [DOI] [PubMed] [Google Scholar]
  2. Barbeau D., Charbonneau R., Whalen S. G., Bayley S. T., Branton P. E. Functional interactions within adenovirus E1A protein complexes. Oncogene. 1994 Feb;9(2):359–373. [PubMed] [Google Scholar]
  3. Barrett P., Clark L., Hay R. T. A cellular protein binds to a conserved sequence in the adenovirus type 2 enhancer. Nucleic Acids Res. 1987 Mar 25;15(6):2719–2735. doi: 10.1093/nar/15.6.2719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blake M. C., Azizkhan J. C. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol Cell Biol. 1989 Nov;9(11):4994–5002. doi: 10.1128/mcb.9.11.4994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brockmann D., Bury C., Kröner G., Kirch H. C., Esche H. Repression of the c-Jun trans-activation function by the adenovirus type 12 E1A 52R protein correlates with the inhibition of phosphorylation of the c-Jun activation domain. J Biol Chem. 1995 May 5;270(18):10754–10763. doi: 10.1074/jbc.270.18.10754. [DOI] [PubMed] [Google Scholar]
  6. Brockmann D., Tries B., Esche H. Isolation and characterization of novel adenovirus type 12 E1A mRNAs by cDNA PCR technique. Virology. 1990 Dec;179(2):585–590. doi: 10.1016/0042-6822(90)90125-b. [DOI] [PubMed] [Google Scholar]
  7. Buchkovich K., Dyson N., Whyte P., Harlow E. Cellular proteins that are targets for transformation by DNA tumour viruses. Ciba Found Symp. 1990;150:262–278. doi: 10.1002/9780470513927.ch16. [DOI] [PubMed] [Google Scholar]
  8. Byrd P. J., Grand R. J., Gallimore P. H. Differential transformation of primary human embryo retinal cells by adenovirus E1 regions and combinations of E1A + ras. Oncogene. 1988 May;2(5):477–484. [PubMed] [Google Scholar]
  9. Cao L., Faha B., Dembski M., Tsai L. H., Harlow E., Dyson N. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature. 1992 Jan 9;355(6356):176–179. doi: 10.1038/355176a0. [DOI] [PubMed] [Google Scholar]
  10. Chellappan S. P., Hiebert S., Mudryj M., Horowitz J. M., Nevins J. R. The E2F transcription factor is a cellular target for the RB protein. Cell. 1991 Jun 14;65(6):1053–1061. doi: 10.1016/0092-8674(91)90557-f. [DOI] [PubMed] [Google Scholar]
  11. Christensen J. B., Imperiale M. J. Inactivation of the retinoblastoma susceptibility protein is not sufficient for the transforming function of the conserved region 2-like domain of simian virus 40 large T antigen. J Virol. 1995 Jun;69(6):3945–3948. doi: 10.1128/jvi.69.6.3945-3948.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Claudio P. P., Howard C. M., Baldi A., De Luca A., Fu Y., Condorelli G., Sun Y., Colburn N., Calabretta B., Giordano A. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res. 1994 Nov 1;54(21):5556–5560. [PubMed] [Google Scholar]
  13. Corbeil H. B., Whyte P., Branton P. E. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene. 1995 Sep 7;11(5):909–920. [PubMed] [Google Scholar]
  14. Dalton S. Cell cycle regulation of the human cdc2 gene. EMBO J. 1992 May;11(5):1797–1804. doi: 10.1002/j.1460-2075.1992.tb05231.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dorsman J. C., Teunisse A. F., Zantema A., van der Eb A. J. The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300. J Gen Virol. 1997 Feb;78(Pt 2):423–426. doi: 10.1099/0022-1317-78-2-423. [DOI] [PubMed] [Google Scholar]
  16. Egan C., Bayley S. T., Branton P. E. Binding of the Rb1 protein to E1A products is required for adenovirus transformation. Oncogene. 1989 Mar;4(3):383–388. [PubMed] [Google Scholar]
  17. Fattaey A. R., Harlow E., Helin K. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol Cell Biol. 1993 Dec;13(12):7267–7277. doi: 10.1128/mcb.13.12.7267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Giordano A., McCall C., Whyte P., Franza B. R., Jr Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product. Oncogene. 1991 Mar;6(3):481–485. [PubMed] [Google Scholar]
  19. Glenn G. M., Ricciardi R. P. Detailed kinetics of adenovirus type-5 steady-state transcripts during early infection. Virus Res. 1988 Jan;9(1):73–91. doi: 10.1016/0168-1702(88)90051-2. [DOI] [PubMed] [Google Scholar]
  20. Harlow E., Whyte P., Franza B. R., Jr, Schley C. Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol. 1986 May;6(5):1579–1589. doi: 10.1128/mcb.6.5.1579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Herrmann C. H., Su L. K., Harlow E. Adenovirus E1A is associated with a serine/threonine protein kinase. J Virol. 1991 Nov;65(11):5848–5859. doi: 10.1128/jvi.65.11.5848-5859.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hiebert S. W., Chellappan S. P., Horowitz J. M., Nevins J. R. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 1992 Feb;6(2):177–185. doi: 10.1101/gad.6.2.177. [DOI] [PubMed] [Google Scholar]
  23. Ho S. N., Hunt H. D., Horton R. M., Pullen J. K., Pease L. R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989 Apr 15;77(1):51–59. doi: 10.1016/0378-1119(89)90358-2. [DOI] [PubMed] [Google Scholar]
  24. Houweling A., van den Elsen P. J., van der Eb A. J. Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA. Virology. 1980 Sep;105(2):537–550. doi: 10.1016/0042-6822(80)90054-9. [DOI] [PubMed] [Google Scholar]
  25. Howe J. A., Bayley S. T. Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A. Virology. 1992 Jan;186(1):15–24. doi: 10.1016/0042-6822(92)90057-v. [DOI] [PubMed] [Google Scholar]
  26. Jelinek T., Graham F. L. Recombinant human adenoviruses containing hybrid adenovirus type 5 (Ad5)/Ad12 E1A genes: characterization of hybrid E1A proteins and analysis of transforming activity and host range. J Virol. 1992 Jul;66(7):4117–4125. doi: 10.1128/jvi.66.7.4117-4125.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jelinek T., Pereira D. S., Graham F. L. Tumorigenicity of adenovirus-transformed rodent cells is influenced by at least two regions of adenovirus type 12 early region 1A. J Virol. 1994 Feb;68(2):888–896. doi: 10.1128/jvi.68.2.888-896.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jelsma T. N., Howe J. A., Mymryk J. S., Evelegh C. M., Cunniff N. F., Bayley S. T. Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer, and induction of proliferating cell nuclear antigen. Virology. 1989 Jul;171(1):120–130. doi: 10.1016/0042-6822(89)90518-7. [DOI] [PubMed] [Google Scholar]
  29. Johnson D. G., Schwarz J. K., Cress W. D., Nevins J. R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature. 1993 Sep 23;365(6444):349–352. doi: 10.1038/365349a0. [DOI] [PubMed] [Google Scholar]
  30. Kim Y. K., Lee A. S. Identification of a 70-base-pair cell cycle regulatory unit within the promoter of the human thymidine kinase gene and its interaction with cellular factors. Mol Cell Biol. 1991 Apr;11(4):2296–2302. doi: 10.1128/mcb.11.4.2296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kirch H. C., Pützer B., Schwabe G., Gnauck H. K., Schulte Holthausen H. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation. Cell Mol Biol Res. 1993;39(8):705–716. [PubMed] [Google Scholar]
  32. Kleinberger T., Shenk T. A protein kinase is present in a complex with adenovirus E1A proteins. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11143–11147. doi: 10.1073/pnas.88.24.11143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lamberti C., Williams J. Differential requirement for adenovirus type 12 E1A gene products in oncogenic transformation. J Virol. 1990 Oct;64(10):4997–5007. doi: 10.1128/jvi.64.10.4997-5007.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Larose A., Dyson N., Sullivan M., Harlow E., Bastin M. Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. J Virol. 1991 May;65(5):2308–2313. doi: 10.1128/jvi.65.5.2308-2313.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Lavery D. J., Chen-Kiang S. Adenovirus E1A and E1B genes are regulated posttranscriptionally in human lymphoid cells. J Virol. 1990 Nov;64(11):5349–5359. doi: 10.1128/jvi.64.11.5349-5359.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lewis J. B., Mathews M. B. Control of adenovirus early gene expression: a class of immediate early products. Cell. 1980 Aug;21(1):303–313. doi: 10.1016/0092-8674(80)90138-5. [DOI] [PubMed] [Google Scholar]
  37. Licht J. D., Grossel M. J., Figge J., Hansen U. M. Drosophila Krüppel protein is a transcriptional repressor. Nature. 1990 Jul 5;346(6279):76–79. doi: 10.1038/346076a0. [DOI] [PubMed] [Google Scholar]
  38. Manohar C. F., Kratochvil J., Thimmapaya B. The adenovirus EII early promoter has multiple EIA-sensitive elements, two of which function cooperatively in basal and virus-induced transcription. J Virol. 1990 Jun;64(6):2457–2466. doi: 10.1128/jvi.64.6.2457-2466.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Mayol X., Graña X., Baldi A., Sang N., Hu Q., Giordano A. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene. 1993 Sep;8(9):2561–2566. [PubMed] [Google Scholar]
  40. Moran E. DNA tumor virus transforming proteins and the cell cycle. Curr Opin Genet Dev. 1993 Feb;3(1):63–70. doi: 10.1016/s0959-437x(05)80342-9. [DOI] [PubMed] [Google Scholar]
  41. Murphy M., Opalka B., Sajaczkowski R., Schulte-Holthausen H. Definition of a region required for transformation in E1a of adenovirus 12. Virology. 1987 Jul;159(1):49–56. doi: 10.1016/0042-6822(87)90346-1. [DOI] [PubMed] [Google Scholar]
  42. Pearson B. E., Nasheuer H. P., Wang T. S. Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells. Mol Cell Biol. 1991 Apr;11(4):2081–2095. doi: 10.1128/mcb.11.4.2081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Phelps W. C., Bagchi S., Barnes J. A., Raychaudhuri P., Kraus V., Münger K., Howley P. M., Nevins J. R. Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. J Virol. 1991 Dec;65(12):6922–6930. doi: 10.1128/jvi.65.12.6922-6930.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pützer B. M., Gnauck J., Kirch H. C., Brockmann D., Esche H. A cis-acting element 7 bp upstream of the ESF-1-binding motif is involved in E1A 13S autoregulation of the adenovirus 12 TS2 promoter. J Gen Virol. 1997 Apr;78(Pt 4):879–891. doi: 10.1099/0022-1317-78-4-879. [DOI] [PubMed] [Google Scholar]
  45. Raychaudhuri P., Bagchi S., Devoto S. H., Kraus V. B., Moran E., Nevins J. R. Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev. 1991 Jul;5(7):1200–1211. doi: 10.1101/gad.5.7.1200. [DOI] [PubMed] [Google Scholar]
  46. Salewski E., Werner G., Opalka B., Schwarz E., Schulte Holthausen H. Genome structure of adenovirus 12 host range mutants adapted to growth in simian Vero cells. Intervirology. 1989;30(1):44–51. doi: 10.1159/000150075. [DOI] [PubMed] [Google Scholar]
  47. Shirodkar S., Ewen M., DeCaprio J. A., Morgan J., Livingston D. M., Chittenden T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell. 1992 Jan 10;68(1):157–166. doi: 10.1016/0092-8674(92)90214-w. [DOI] [PubMed] [Google Scholar]
  48. Slansky J. E., Li Y., Kaelin W. G., Farnham P. J. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol. 1993 Mar;13(3):1610–1618. doi: 10.1128/mcb.13.3.1610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Smits P. H., de Wit L., van der Eb A. J., Zantema A. The adenovirus E1A-associated 300 kDa adaptor protein counteracts the inhibition of the collagenase promoter by E1A and represses transformation. Oncogene. 1996 Apr 4;12(7):1529–1535. [PubMed] [Google Scholar]
  50. Solnick D., Anderson M. A. Transformation-deficient adenovirus mutant defective in expression of region 1A but not region 1B. J Virol. 1982 Apr;42(1):106–113. doi: 10.1128/jvi.42.1.106-113.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Subramanian T., Kuppuswamy M., Nasr R. J., Chinnadurai G. An N-terminal region of adenovirus E1a essential for cell transformation and induction of an epithelial cell growth factor. Oncogene. 1988 Feb;2(2):105–112. [PubMed] [Google Scholar]
  52. Telling G. C., Williams J. Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12. J Virol. 1994 Feb;68(2):877–887. doi: 10.1128/jvi.68.2.877-887.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Van der Eb A. J., Mulder C., Graham F. L., Houweling A. Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA. Gene. 1977;2(3-4):115–132. doi: 10.1016/0378-1119(77)90012-9. [DOI] [PubMed] [Google Scholar]
  54. Wang H. G., Yaciuk P., Ricciardi R. P., Green M., Yokoyama K., Moran E. The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300. J Virol. 1993 Aug;67(8):4804–4813. doi: 10.1128/jvi.67.8.4804-4813.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Werner G., zur Hausen H. Deletions and insertions in adenovirus type 12 DNA after viral replication in Vero cells. Virology. 1978 May 1;86(1):66–77. doi: 10.1016/0042-6822(78)90008-9. [DOI] [PubMed] [Google Scholar]
  56. Whyte P., Ruley H. E., Harlow E. Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol. 1988 Jan;62(1):257–265. doi: 10.1128/jvi.62.1.257-265.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Whyte P., Williamson N. M., Harlow E. Cellular targets for transformation by the adenovirus E1A proteins. Cell. 1989 Jan 13;56(1):67–75. doi: 10.1016/0092-8674(89)90984-7. [DOI] [PubMed] [Google Scholar]
  58. Wolf D. A., Hermeking H., Albert T., Herzinger T., Kind P., Eick D. A complex between E2F and the pRb-related protein p130 is specifically targeted by the simian virus 40 large T antigen during cell transformation. Oncogene. 1995 Jun 1;10(11):2067–2078. [PubMed] [Google Scholar]
  59. Yee S. P., Branton P. E. Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides. Virology. 1985 Nov;147(1):142–153. doi: 10.1016/0042-6822(85)90234-x. [DOI] [PubMed] [Google Scholar]
  60. Zalvide J., DeCaprio J. A. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol Cell Biol. 1995 Oct;15(10):5800–5810. doi: 10.1128/mcb.15.10.5800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. van den Hoff M. J., Moorman A. F., Lamers W. H. Electroporation in 'intracellular' buffer increases cell survival. Nucleic Acids Res. 1992 Jun 11;20(11):2902–2902. doi: 10.1093/nar/20.11.2902. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES